TORONTO, ONTARIO--(Marketwired - July 2, 2015) -


LDIC Inc. ("LDIC" or the "Manager") is pleased to announce the exchange ratios for the Exchange Option being made under the final prospectus dated June 26, 2015 of Healthcare Special Opportunities Fund (the "Fund") for an initial public offering of Class A Units and Class U Units at a price of $10.00 per Class A Unit and U.S.$10.00 per Class U Unit.

The Fund's investment objective is to provide Unitholders with long-term total return through distributions and capital appreciation of the Fund's investment portfolio. The Fund has been created to invest in an actively managed portfolio comprised primarily of publicly traded issuers and private issuers that derive a significant portion of their revenue or earnings from medical and healthcare products and/or services. The Fund may invest up to 20% of the Fund's total assets in private equity investments to provide investors with exposure to a limited number of investments that the Manager believes have potential for significant upside.

LDIC will be responsible for the execution of the Fund's overall investment strategy, including managing the composition of the Portfolio. Canons Park Advisors, Inc., carrying on business as Dalsin Greene Advisors, will provide LDIC with ongoing analysis regarding the global healthcare sector, including private equity investments.

Prospective purchasers investing in the Fund will have the option of paying for Units in cash or by exchanging securities of issuers listed below. Prospective purchasers under the Exchange Option are required to deposit their Exchange Eligible Securities prior to 5:00 p.m. (Toronto time) on July 10, 2015. Such deposits must be made in the form of a book-entry deposit with Equity Financial Trust Company, the Fund's agent for the Exchange Option, through CDS Clearing and Depository Services Inc. ("CDS"). Investment dealers, who will make these deposits through CDS, may have an earlier deadline for receiving instructions from investment advisors to deposit securities under the Exchange Option.

The number of Units issuable for each class of security of an Exchange Eligible Issuer (the "Exchange Ratio") has been determined by dividing the weighted average trading price of such security on the Toronto Stock Exchange (the "TSX") (or such other exchange or market on which such security is then listed) during the period of five consecutive trading days ended on June 30, 2015 (the "Pricing Period"), as adjusted to reflect distributions declared by any Exchange Eligible Issuer that will not be received by the Fund, by $10.00. The Exchange Ratio for any such securities that do not trade in Canadian dollars was determined by converting the weighted average trading price on the applicable exchange of such securities into Canadian dollars based on the WM/Reuters closing spot U.S. dollar/Canadian dollar exchange rate on the last day of the Pricing Period. Holders of securities of Exchange Eligible Issuers who deposited such securities pursuant to the Exchange Option will continue to be holders of record up to but not including the date of the closing of this offering and will be entitled to receive distributions in respect of such securities of Exchange Eligible Issuers that are declared up to but not including such date. The Fund will not issue fractional Units pursuant to the Exchange Option.

If for any reason Exchange Eligible Securities deposited pursuant to the Exchange Option are not acquired by the Fund, the holders of such securities will be notified of such fact as soon as practicable following the closing or the termination of this Offering, as the case may be, and such securities will be re-credited to their accounts through CDS.

The table below sets out the Exchange Eligible Issuers, their ticker symbol, CUSIP number, ISIN number, volume weighted average trading price during the Pricing Period and the Exchange Ratio.

Abbott Laboratories ABT 002824100 US0028241000 61.84684 6.18468
AbbVie Inc. ABBV 00287Y109 US00287Y1091 86.10232 8.61023
Aetna Inc. AET 00817Y108 US00817Y1082 161.47929 16.14793
Aflac Incorporated AFL 001055102 US0010551028 78.44505 7.84450
ageas SA/NV AGESY 00844W208 US00844W2089 48.57189 4.85719
Agilent Technologies Inc A 00846U101 US00846U1016 49.60486 4.96049
Alaris Royalty Corp. AD 01163Q400 CA01163Q4007 30.83840 3.08384
Alexion Pharmaceuticals Inc. ALXN 015351109 US0153511094 229.22496 22.92250
Alimentation Couche-Tard Inc. ATD/B 01626P403 CA01626P4033 53.57110 5.35711
Alkermes plc ALKS 00B56GVS1 IE00B56GVS15 81.00800 8.10080
Allianz SE ALV 018805101 US0188051017 149.06978 14.90698
Allied Properties Real Estate Investment Trust AP-U 019456102 CA0194561027 35.70320 3.57032
AmerisourceBergen Corp. ABC 03073E105 US03073E1055 134.55374 13.45537
Amgen Inc. AMGN 031162100 US0311621009 195.19070 19.51907
Amica Mature Lifestyles Inc. ACC 031498207 CA0314982079 8.03860 0.80386
Anthem Inc. ANTM 036752103 US0367521038 208.07164 20.80716
Artis Real Estate Investment Trust AX-U 04315L105 CA04315L1058 13.71810 1.37181
AstraZenica plc AZN 046353108 US0463531089 81.20563 8.12056
Bank of Montreal BMO 063671101 CA0636711016 75.09760 7.50976
Baxter International Inc. BAX 071813109 US0718131099 89.41085 8.94109
Bayer AG BAYRY 072730302 US0727303028 181.01499 18.10150
BCE Inc. BCE 05534B760 CA05534B7604 53.77410 5.37741
Becton, Dickinson and Company BDX 075887109 US0758871091 177.48112 17.74811
Biogen Inc. BIIB 09062X103 US09062X1037 507.69623 50.76962
BioMarin Pharmaceuticals Inc. BMRN 09061G101 US09061G1013 168.76328 16.87633
Boston Scientific Corporation BSX 101137107 US1011371077 22.47157 2.24716
Bristol-Myers Squibb Co. BMY 110122108 US1101221083 83.72115 8.37211
Brookdale Senior Living Inc. BKD 112463104 US1124631045 44.32365 4.43236
Brookfield Asset Management Inc. BAM/A 112585104 CA1125851040 44.21510 4.42151
Brookfield Property Partners LP BPY-U N/A BMG162491077 27.52380 2.75238
Calloway Real Estate Investment Trust CWT-U 131253205 CA1312532056 29.04240 2.90424
Canadian Imperial Bank of Commerce CM 136069101 CA1360691010 94.17030 9.41703
Canadian Western Bank CWB 13677F101 CA13677F1018 29.46510 2.94651
Cardinal Health, Inc. CAH 14149Y108 US14149Y1082 107.18810 10.71881
Catamaran Corporation (formerly SXC Health Solutions Corp.) CCT 148887102 CA1488871023 75.64630 7.56463
Celgene Corporation CELG 151020104 US1510201049 146.70271 14.67027
Centene Corporation CNC 15135B101 US15135B1017 100.38989 10.03899
Cerner Corporation CERN 156782104 US1567821046 86.07161 8.60716
CGI Group Inc. GIB/A 39945C109 CA39945C1095 50.02910 5.00291
Chartwell Retirement Residences CSH-U 16141A103 CA16141A1030 11.50120 1.15012
Chemed Corporation CHE-U 16359R103 US16359R1032 25.48871 2.54887
Cigna Corp. CI 125509109 US1255091092 208.34193 20.83419
Community Health Systems, Inc. CYH 203668108 US2036681086 77.30321 7.73032
Concordia Healthcare Corp. CXR 206519100 CA2065191009 92.72420 9.27242
Crombie Real Estate Investment Trust CRR-U 227107109 CA2271071094 12.54710 1.25471
CVS Health Corp. CVS 126650100 US1266501006 131.78954 13.17895
DaVita Healthcare Partners, Inc. DVA 23918K108 US23918K1088 100.48253 10.04825
Dream Global Real Estate Investment Trust (formerly, Dundee International Real Estate Investment Trust) DRG-U 26154A106 CA26154A1066 10.01060 1.00106
Dream Office Real Estate Investment Trust (formerly, Dundee Real Estate Investment Trust) D-U 26153P104 CA26153P1045 24.78930 2.47893
Edwards Lifesciences Corp. EW 28176E108 US28176E1082 180.30100 18.03010
Eli Lilly & Co. LLY 532457108 US5324571083 106.13853 10.61385
Empire Company Limited EMP/A 291843407 CA2918434077 89.92800 8.99280
Endo International plc ENL G30401106 IE00BJ3V9050 60.02085 6.00208
Express Scripts Holding Company ESRX 30219G108 US30219G1085 113.03025 11.30303
Extendicare Inc. EXE 30224T863 CA30224T8639 7.57020 0.75702
Fidelity MSCI Health Care Index ETF FHLC 316092600 US3160926008 45.61518 4.56152
First Capital Realty Inc. FCR 31943B100 CA31943B1004 17.98500 1.79850
First Trust Health Care AlphaDEX Fund FXH 33734X143 US33734X1431 86.11631 8.61163
Fresenius Medical Care AG & Co. FMS 358029106 US3580291066 52.96134 5.29613
George Weston Limited WN 961148509 CA9611485090 100.78420 10.07842
Gilead Sciences Inc. GILD 375558103 US3755581036 148.80473 14.88047
GlaxoSmithKline plc GSK 37733W105 US37733W1053 53.37420 5.33742
Granite Real Estate Investment Trust GRT-U 387437114 CA3874371147 43.57340 4.35734
Great-West Lifeco Inc. GWO 39138C106 CA39138C1068 37.10560 3.71056
H&R Real Estate Investment Trust HR-U 404428203 CA4044282032 22.35950 2.23595
HCA Holdings, Inc. HCA 40412C101 US40412C1018 112.85085 11.28508
HCP, Inc. HCP 40414L109 US40414L1098 45.90707 4.59071
Health Care REIT HCN 42217K106 US42217K1060 82.81077 8.28108
Healthcare SPDR ETF XLV 81369Y209 US81369Y2090 94.16222 9.41622
Healthcare Trust of America, Inc. HTA 42225P501 US42225P5017 29.87091 2.98709
Hologic, Inc. HOLX 436440101 US 4364401012 47.45840 4.74584
Hospira, Inc. HSP 441060100 US4410601003 110.71624 11.07162
Humana Inc. HUM 444859102 US4448591028 242.25458 24.22546
Illumina, Inc. ILMN 452327109 US 4523271090 272.78118 27.27812
Incycte Corporation INCY 45337C102 US45337C1027 129.84494 12.98449
Intuitive Surgical, Inc. ISRG 46120E602 US46120E6023 615.21430 61.52143
iShares Global Healthcare Index ETF (CAD-Hedged) XHC 46431R102 CA46431R1029 43.37640 4.33764
iShares S&P Global Healthcare Sector ETF IXJ 464287325 US4642873255 137.42931 13.74293
iShares S&P/TSX 60 Index ETF XIU 46428D108 CA46428D1087 21.65700 2.16570
iShares U.S. Healthcare ETF IYH 464287762 US4642877629 200.19139 20.01914
iShares U.S. Healthcare Providers ETF IHF 464288828 US4642888287 180.02210 18.00221
Isis Pharmaceuticals, Inc. ISIS 464330109 US4643301090 73.74274 7.37427
Johnson & Johnson JNJ 478160104 US4781601046 123.45023 12.34502
Laboratory Corporation of America Holdings. LH 50540R409 US50540R4092 150.46792 15.04679
Loblaw Companies Limited L 539481101 CA5394811015 64.53330 6.45333
Manulife Financial Corporation MFC 56501R106 CA56501R1064 23.75210 2.37521
McKesson Corporation MCK 58155Q103 US58155Q1031 285.05524 28.50552
Medivation, Inc. MDVN 58501N101 US58501N1019 140.90276 14.09028
Medtronic plc MDT N/A IE00BTN1Y115 93.60554 9.36055
Merck & Co Inc. MRK 58933Y105 US58933Y1055 72.34385 7.23438
Metro Inc. MRU 59162N109 CA59162N1096 33.75380 3.37538
Mylan N.V. MYL 001103120 NL0011031208 86.64103 8.66410
National Bank of Canada NA 633067103 CA6330671034 47.53150 4.75315
Novartis AG NVS 66987V109 US66987V1098 124.28245 12.42825
Novo Nordisk A/S NVO 670100205 US6701002056 69.33195 6.93320
Opko Health, Inc. OPK 68375N103 US68375N1037 19.76978 1.97698
Perrigo Company plc. PRGO 714290103 IE00BGH1M568 234.29094 23.42909
Pfizer Inc. PFE 717081103 US7170811035 42.32725 4.23272
Power Corporation of Canada POW 739239101 CA7392391016 32.75770 3.27577
Power Financial Corporation PWF 73927C100 CA73927C1005 36.39640 3.63964
Procter & Gamble Co. PG 742718109 US7427181091 98.87589 9.88759
Pure Industrial Real Estate Trust AAR-U 74623T108 CA74623T1084 4.74900 0.47490
Quest Diagnostics Incorporated DGX 74834L100 US74834L1008 90.39564 9.03956
Regal Lifestyle Communities Inc. RLC 75882T101 CA75882T1012 12.01310 1.20131
ResMed Inc. RMD 761152107 US7611521078 70.07366 7.00737
RioCan Real Estate Investment Trust REI-U 766910103 CA7669101031 26.89600 2.68960
Roche Holding AG RHHBY 771195104 US7711951043 44.55773 4.45577
Rogers Communications Inc. RCI/B 775109200 CA7751092007 43.51980 4.35198
Royal Bank of Canada RY 780087102 CA7800871021 77.60930 7.76093
Sanofi S.A. SNY 80105N105 US80105N1054 63.66671 6.36667
Seattle Genetics, Inc. SGEN 812578102 US8125781026 59.56329 5.95633
Shaw Communications Inc. SJR/B 82028K200 CA82028K2002 27.55360 2.75536
Shire plc SHPG 82481R106 US82481R1068 308.84892 30.88489
Sienna Senior Living Inc. SIA 82621K102 CA82621K1021 15.54610 1.55461
St. Jude Medical, Inc. STJ 790849103 US7908491035 92.52438 9.25244
Stryker Corporation SYK 863667101 US8636671013 120.64033 12.06403
Sun Life Financial Inc. SLF 866796105 CA8667961053 42.58610 4.25861
TELUS Corp. T 87971M103 CA87971M1032 42.85710 4.28571
Tenet Healthcare Corporation THC 88033G407 US88033G4073 69.88077 6.98808
Teva Pharmaceutical Industries Ltd. TEVA 881624209 US8816242098 73.99456 7.39946
The Bank of Nova Scotia BNS 064149107 CA0641491075 65.92930 6.59293
The Jean Coutu Group (PJC) Inc. PJC/A 47215Q104 CA47215Q1046 23.00600 2.30060
The Toronto-Dominion Bank TD 891160509 CA8911605092 53.92950 5.39295
Thermo Fisher Scientific Inc. TMO 883556102 US8835561023 163.67820 16.36782
Thomson Reuters Corporation TRI 884903105 CA8849031056 48.02730 4.80273
UnitedHealth Group Inc. UNH 91324P102 US91324P1021 152.79741 15.27974
Universal Health Services, Inc. UHS 913903100 US9139031002 174.18070 17.41807
Valeant Pharmaceuticals International, Inc. VRX 91911K102 CA91911K1021 281.27760 28.12776
Vanguard Health Care ETF VHT 92204A504 US92204A5048 176.38397 17.63840
Ventas, Inc. VTR 92276F100 US92276F1003 78.11246 7.81125
Vertex Pharmaceuticals Incorporated VRTX 92532F100 US92532F1003 127.10640 12.71064
Walgreens Boots Alliance, Inc. WBA 931427108 US9314271084 107.56913 10.75691
Zoetis Inc. ZTS 98978V103 US98978V1035 62.08592 6.20859

The syndicate of agents for the Offering is being co-led by BMO Capital Markets and Scotiabank, and includes Canaccord Genuity Corp., GMP Securities L.P., Mackie Research Capital Corporation, Salman Partners Inc., Desjardins Securities Inc., Dundee Securities Ltd., Global Securities Corporation, Industrial Alliance Securities Inc., Laurentian Bank Securities Inc., and PI Financial Corp. (collectively, the "Agents").

Certain statements included in this news release constitute forward-looking statements, including, but not limited to, those identified by the expressions "expect", "intend", "will", and similar expressions to the extent they relate to the Fund and/or the Manager. The forward-looking statements are not historical facts but reflect the Fund's and/or the Manager's current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Although the Fund and/or the Manager believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, readers are cautioned not to place undue reliance on such statements due to the inherent uncertainty therein. The Fund and/or the Manager undertake no obligation to update publicly or otherwise revise any forward-looking statement or information whether as a result of new information, future events or other such factors which affect this information, except as required by law.

A final prospectus dated June 26, 2015 (the "Prospectus") containing important information relating to these securities has been filed with securities commissions or similar authorities in each of the provinces of Canada. Copies of the Prospectus may be obtained from any of the Agents. There will not be any sale or any acceptance of an offer to buy the securities until a receipt for the final prospectus has been issued.

All capitalized terms noted herein but not defined are as defined in the Prospectus.

For additional information or a copy of the Prospectus, please contact your registered financial advisor.

Contact Information:

Genevieve Roch-Decter